Biomedtracker: 開発中医薬品をFDA承認確率で評価, Meddevicetracker: 医療機器の市場調...
Q4 2019 Outlook Report Extract
16 Oct 2019
What major drug catalysts and events can you expect to see this quarter? Get a view of what's to come with an extract from the full report.
Medtech Insight(メドテックインサイト)では、世界の医療機器・医療技術に関する最新の開発状況(臨床試験の結果、承認審査、市販後の更新情報等)や投資動向、ディール活動、参入企業の動きなど医療機器・医療技術産業全体の最新情報をお伝えします。
欧州、米国、アジアの各地に拠点を置く経験豊富なジャーナリスト＆アナリストが、独自の分析と業界のオピニオンリーダーの考えを交えてニュースをお伝えします。FDAの警告書をモニターするMedtech Insight trackerにもアクセスできます。
下記のようなニーズにお応えします
Medtech Insightのページにアクセスすると、各記事の冒頭部分のみご覧になれます。お気軽に無料トライアルもお試しください。
Biomedtracker: 開発中医薬品をFDA承認確率で評価, Meddevicetracker: 医療機器の市場調...
16 Oct 2019
What major drug catalysts and events can you expect to see this quarter? Get a view of what's to come with an extract from the full report.
Biomedtracker: 開発中医薬品をFDA承認確率で評価
16 Oct 2019
What were the outcomes of critical catalysts featured in Biomedtracker’s Q3 2019 Outlook Report? Find out in the Catalyst Roundup: A Review of Select Catalysts from Last Quarter’s Outlook Report. This data-rich graphic is available now – for free.
Topic Drug approval Drug review FDA
Biomedtracker: 開発中医薬品をFDA承認確率で評価, Datamonitor Healthcare: 医療...
27 Sep 2019
Take a longer-term look at key late-stage drugs projected to hit the market in 2020, including new drug classes, major changes to standards of care, and/or large market opportunities across the wide range of indications covered by Biomedtracker and Datamonitor Healthcare.
Biomedtracker: 開発中医薬品をFDA承認確率で評価
04 Sep 2019
Discover how creating custom company portfolios can help you overcome your toughest business challenges.
Topic business-strategies
Biomedtracker: 開発中医薬品をFDA承認確率で評価
29 Jul 2019
In this report, we cover catalysts from 27 drugs, devices and diagnostics expected to occur in Q3 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.
Topic Drug development landscape Drug review Research Strategy
Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Biomedtracker: 開発中医...
15 Jul 2019
Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019.
Meddevicetracker: 医療機器の市場調査分析・データベース, Biomedtracker: 開発中医薬品を...
05 Jul 2019
Staying on top of what’s going in the competitive Medtech market and getting a complete view of the competitive landscape and current market trends is critical to your business. Often, this essential information is fragmented and difficult to find, and gathering and synthesizing it is tedious and time consuming. Now, Biomedtracker puts this critical information at your fingertips, saving you time and effort. The new “Associated Products” section on relevant Biomedtracker Drug Profile pages shows you the full competitive landscape – including drugs, devices, and diagnostics – with a single search.
Topic business-strategies medtech
Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Biomedtracker: 開発中医...
By Michael Haydock 02 Jul 2019
Find out which market-moving events and catalysts to watch for during the Q1 Outlook Webinar - Key catalysts and their impact on pharma markets.
Biomedtracker: 開発中医薬品をFDA承認確率で評価
02 Jul 2019
A Review of Select Catalysts from Last Quarter’s Outlook Report.
Topic clinical-trials drug-approval drug-review drug-development-landscape
Meddevicetracker: 医療機器の市場調査分析・データベース, Biomedtracker: 開発中医薬品を...
03 May 2019
In this report, we cover catalysts from 25 drugs, devices and diagnostics expected to occur in Q2 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.
Biomedtracker: 開発中医薬品をFDA承認確率で評価, Datamonitor Healthcare: 医療...
10 Apr 2019
3 – 9 December is National Influenza Vaccination Week, a national awareness week focused on highlighting the importance of influenza vaccination. In this free KOL Insight Interview excerpt from Datamonitor Healthcare, read what key opinion leaders from the UK and US in Infectious Diseases have to say about current efforts to combat influenza with seasonal influenza vaccines:
Biomedtracker: 開発中医薬品をFDA承認確率で評価
10 Apr 2019
What's on the horizon for pharma in 2018? Find out with Biomedtracker's Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.
Biomedtracker: 開発中医薬品をFDA承認確率で評価, Meddevicetracker: 医療機器の市場調...
10 Apr 2019
In this report, we cover catalysts from 23 drugs, devices and diagnostics expected to occur in early 2019.
Topic drug-approval drug-review medtech
Biomedtracker: 開発中医薬品をFDA承認確率で評価
19 Nov 2018
Understand important upcoming milestones that will impact the likelihood of drug approval or future sales potential for key therapies during a free webinar from Informa Pharma Intelligence, "Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets".
Biomedtracker: 開発中医薬品をFDA承認確率で評価
19 Oct 2018
Find out what’s in store for the remainder of 2018 with your copy of the Biomedtracker Q4 2018 Outlook Report Extract. This essential analysis of expected Q4 catalysts for 27 drugs is now available to you – for free. Drawn from the full report of the same name, this vital resource explores the likelihood of phase/PDUFA review success and overall Likelihood of Approval (LOA) based on a drug’s phase, drug class, and disease group.
Amanda specializes in
+35 year(s) experience
Neena specializes in
+32 year(s) experience
Ian specializes in
+31 year(s) experience
In Vivo(インビボ)は、医療用医薬品の企業全般、バイオ医薬品企業、医療機器・診断機器メーカーの経営層・トップマネジメントを対象としたニュース配信サービスです。35年以上の経験を有するベテランの専門記者とアナリストが様々な観点から今日の医薬品産業を分析し、経営層のハイレベルかつグローバルな情報ニーズに応えるニュースや読み応えのある記事を提供しています。
Meddevicetracker(メッドデバイストラッカー)は、医療機器の開発状況について適応疾患や医療機器のタイプから検索できるツールです。1,000社以上の会社による5,000を超える製品群、2,000件以上の医療機器の臨床試験など比類ない規模で医療機器市場を網羅しています。
無料トライアルお申込み
お問い合わせ先
ご質問等ございましたらお気軽にご連絡下さい。
日本（平日：9時～18時）
電話：+81 (0)3 6273 4260
Email：inquiry.jp@informa.com
レポートストア
オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。
お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。